The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats

Na WuDepartment of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China, [email protected]; [email protected]

Ying WanDepartment of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China, [email protected]; [email protected]

Lu SongDepartment of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China, [email protected]; [email protected]

Chen QiDepartment of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China, [email protected]; [email protected]

Zhenguo LiuDepartment of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Jing GanDepartment of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Pages 1779-1786 | Published online: 05 Jul 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MosharovEVBorgkvistASulzerDPresynaptic effects of levodopa and their possible role in dyskinesiaMov Disord2015301455325450307
PubMed Web of Science ®Google Scholar
ManoharanSGuilleminGJAbiramasundariRSEssaMMAkbarMAkbarMDThe role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini reviewOxid Med Cell Longev20162016859057828116038
PubMed Web of Science ®Google Scholar
RizekPKumarNJogMSAn update on the diagnosis and treatment of Parkinson diseaseCMAJ2016188161157116527221269
PubMed Web of Science ®Google Scholar
VoonVNapierTCFrankMJImpulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an updateLancet Neurol201716323825028229895
PubMed Web of Science ®Google Scholar
FerrazzoliDCarterAUstunFSDopamine replacement therapy, learning and reward prediction in Parkinson’s disease: implications for rehabilitationFront Behav Neurosci20161012127378872
PubMed Web of Science ®Google Scholar
OertelWSchulzJBCurrent and experimental treatments of Parkinson disease: a guide for neuroscientistsJ Neurochem2016139Suppl 132533727577098
PubMed Web of Science ®Google Scholar
FeyderMBonito-OlivaAFisoneGL-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmissionFront Behav Neurosci201157122028687
PubMed Web of Science ®Google Scholar
SharmaSSinghSSharmaVSinghVPDeshmukhRNeurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategiesBiomed Pharmacother20157028329325776513
PubMed Web of Science ®Google Scholar
CenciMAPresynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implicationsFront Neurol2014524225566170
PubMed Web of Science ®Google Scholar
FrancardoVCenciMAInvestigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouseParkinsonism Relat Disord201420Suppl 1S20S2224262181
PubMedGoogle Scholar
SchaefferEPilottoABergDPharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson’s diseaseCNS Drugs201428121155118425342080
PubMed Web of Science ®Google Scholar
SantiniESgambato-FaureVLiQDistinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesiaPLoS One201058e1232220808799
PubMed Web of Science ®Google Scholar
SvenningssonPNishiAFisoneGGiraultJANairnACGreengardPDARPP-32: an integrator of neurotransmissionAnnu Rev Pharmacol Toxicol20044426929614744247
PubMed Web of Science ®Google Scholar
ValjentEPascoliVSvenningssonPRegulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatumProc Natl Acad Sci U S A2005102249149615608059
PubMed Web of Science ®Google Scholar
GerfenCRPaletzkiRWorleyPDifferences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine-and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinaseJ Neurosci200828287113712018614680
PubMed Web of Science ®Google Scholar
FiorentiniCSavoiaPSavoldiDBarbonAMissaleCPersistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dys-kinesia in the 6-hydroxydopamine rat model of Parkinson’s diseaseNeurobiol Dis20135433934823328768
PubMed Web of Science ®Google Scholar
FiorentiniCMattanzaCColloGSavoiaPSpanoPMissaleCThe tyrosine phosphatase Shp-2 interacts with the dopamine D (1) receptor and triggers D(1) -mediated Erk signaling in striatal neuronsJ Neurochem2011117225326321272002
PubMed Web of Science ®Google Scholar
SantiniEHeimanMGreengardPValjentEFisoneGInhibition of mTOR signaling in Parkinson’s disease prevents L-DOPA-induced dyskinesiaSci Signal2009280ra3619622833
PubMed Web of Science ®Google Scholar
CalabresiPDi FilippoMGhiglieriVTambascoNPicconiBLevodopa-induced dyskinesias in patients with Parkinson’s disease: filling the bench-to-bedside gapLancet Neurol20109111106111720880751
PubMed Web of Science ®Google Scholar
Müller-RebsteinSTrenkwalderCOertelWHCulmseeCEckermannGHöglingerGUPharmacotherapy of Parkinson’s disease: aspects of drug safetyNervenarzt201788888889428497256
PubMed Web of Science ®Google Scholar
SongLZhangZHuRTargeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s ratsDrug Des Devel Ther201610547555
PubMed Web of Science ®Google Scholar
FiorentiniCSavoiaPSavoldiDShp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson’s diseaseMov Disord201631451252026898243
PubMed Web of Science ®Google Scholar
SantiniEFeyderMGangarossaGBateupHSGreengardPFisoneGDopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonismJ Biol Chem201228733278062781222753408
PubMed Web of Science ®Google Scholar
SantiniEValjentEFisoneGmTORC1 signaling in Parkinson’s disease and L-DOPA-induced dyskinesia: a sensitized matterCell Cycle20109142713271820581466
PubMed Web of Science ®Google Scholar
BrugnoliANapolitanoFUsielloAMorariMGenetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striatonigral neurons activation in levodopa-induced dyskinesiaNeurobiol Dis20168515516326522958
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date